Through a business partnership with GP, accelerate overseas expansion and maximize the value of the drug discovery pipeline. In addition to capital provision, receive hands-on support including management support, business development, and DX promotion, and pursue strengthened domestic and international licensing and partnerships and optimization of the business portfolio.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4563","jir_company_name":"AnGes, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4563-20260928-01.pdf","jir_short_summary":"Through a business partnership with GP, accelerate overseas expansion and maximize the value of the drug discovery pipeline. In addition to capital provision, receive hands-on support including management support, business development, and DX promotion, and pursue strengthened domestic and international licensing and partnerships and optimization of the business portfolio.","jir_summary":"### Overview of the Partnership\nAnGes, Inc. has started a business partnership with Growth Partners Co., Ltd. (GP). GP provides hands-on services that include not only capital provision but also management support, business development support, M&A support, DX promotion, and alliance support. Through this, AnGes aims to strengthen licensing activities and business partnerships domestically and internationally, leverage the drug discovery pipeline, and achieve medium- to long-term enhancement of corporate value. The company is currently exchanging opinions on business contents and organizational management and conducting cross-organizational evaluation of GP.\n\n### Future Outlook and Policy\nGoing forward, in collaboration with GP, AnGes will strengthen domestic and international licensing and partnerships, explore new alliance opportunities, optimize the business portfolio, promote business development with overseas markets in view, and enhance IR activities and measures to increase corporate value. In particular, the company aims to promptly realize a sales partner agreement for the HGF gene therapy product and work to maximize the value of the drug discovery pipeline and owned businesses.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#ShareBuybackRelated, #Alliance, #DrugDiscovery, #GeneTherapeutics","jir_key_figures":"Key Figure 1: Unknown (no numerical information provided in the PDF)\nKey Figure 2: Unknown (no numerical information provided in the PDF)\nKey Figure 3: Unknown (no numerical information provided in the PDF)","jir_meta_title":"AnGes, Inc. \u2014 Enhancing Corporate Value through Partnership with GP\uff5cSeptember 2026","jir_meta_description":"AnGes, Inc. and Growth Partners have formed a business partnership to maximize the value of the drug discovery pipeline and strengthen domestic and international alliances. Leveraging hands-on support including capital provision, management, business development, and DX promotion, the company aims for medium- to long-term corporate value enhancement.","jir_og_title":"AnGes, Inc. \u2014 Accelerating Growth through Partnership with GP","jir_og_description":"Through collaboration with Growth Partners, strengthen domestic and international licensing activities and business partnerships. Promote medium- to long-term enhancement of the drug discovery pipeline's value and overseas expansion.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57619,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-123788","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n